T13	Exp 313 315	we
T14	Exp 350 355	which
T15	Exp 242 250	the role
T16	Exp 411 430	the T-lineage cells
T17	Exp 535 557	the thymic development
T18	Exp 635 669	the ex vivo proliferative response
T19	Exp 753 757	that
T20	Exp 758 774	the perturbation
T21	Exp 778 804	the proliferation response
T22	Exp 855 866	these genes
T23	Exp 948 970	the transgenic T cells
T24	Exp 972 1000	The proliferative deficiency
T25	Exp 1004 1026	the transgenic T cells
T26	Exp 1177 1183	either
T27	Exp 1095 1110	the involvement
T28	Exp 1216 1234	the IL-2 signaling
T29	Exp 1271 1297	the cell cycle progression
T30	Exp 1071 1084	These results
R4	Coref Anaphora:T14 Antecedent:T31
T32	SPAN 708 728	IL-2 and IL-2R alpha
R5	Coref Anaphora:T22 Antecedent:T32
T1	Protein 356 360	RelA
T2	Protein 365 370	c-Rel
T3	Protein 482 497	I kappa B alpha
T4	Protein 708 712	IL-2
T5	Protein 717 728	IL-2R alpha
T6	Protein 895 899	IL-4
T7	Protein 901 906	IL-10
T8	Protein 912 921	IFN-gamma
T9	Protein 1220 1224	IL-2
T31	Exp 331 346	transgenic mice
